Related Experiment Videos
Carcinogenesis and the response of tumours to anticancer drugs
Abstract:
Tumour development is the consequence of a multistep process involving the activation of oncogenes and loss of tumour suppressor gene function. The study of molecular alterations which accompany carcinogenesis and distinguish the tumour from its normal cellular counterpart, may provide a basis for the in vivo development of drug resistance and facilitate the rational design of anticancer drugs which exploit these differences. In this review we shal discuss some of the effects of carcinogen exposure in relation to how this may influence the response of a tumour to chemotherapy.
Insights
Tumour development involves genetic changes. Understanding these molecular alterations from carcinogen exposure can guide the design of more effective chemotherapy drugs by exploiting cancer-specific differences.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Tumourigenesis results from oncogene activation and tumour suppressor gene inactivation.
- Molecular changes during carcinogenesis create differences between tumour and normal cells.
- These alterations can influence drug resistance and treatment outcomes.
Purpose of the Study:
- To review the effects of carcinogen exposure on tumour molecular alterations.
- To discuss how these changes impact chemotherapy response.
- To explore rational drug design targeting cancer-specific molecular differences.
Main Methods:
- Literature review of studies on carcinogenesis and chemotherapy.
- Analysis of molecular alterations induced by carcinogens.
- Discussion of mechanisms of drug resistance in tumours.
Main Results:
- Carcinogen exposure induces specific molecular changes in cells.
- These molecular alterations can lead to acquired or intrinsic drug resistance.
- Differences between tumour and normal cells offer therapeutic targets.
Conclusions:
- Understanding carcinogen-induced molecular alterations is crucial for cancer therapy.
- Targeting these specific changes can improve chemotherapy efficacy.
- Exploiting molecular differences facilitates rational anticancer drug design.